Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Unknown 2Recruiting 2Completed 2Terminated 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Leukemia, Myeloid, Acute 76Leukemia 43Precursor Cell Lymphoblastic Leukemia-Lymphoma 16Leukemia, Myelomonocytic, Acute 16Leukemia, Monocytic, Acute 16Congenital Abnormalities 16Leukemia, Megakaryoblastic, Acute 14Leukemia, Erythroblastic, Acute 14Myelodysplastic Syndromes 11Leukemia, Promyelocytic, Acute 8Leukemia, Myelomonocytic, Chronic 8Anemia, Refractory, with Excess of Blasts 8Recurrence 6Myeloproliferative Disorders 5Leukemia, Eosinophilic, Acute 5Leukemia, Basophilic, Acute 4Lymphoma 3Leukemia, Myeloid, Chronic-Phase 3Blast Crisis 3Neutropenia 2Neoplasms 2Lymphoma, Non-Hodgkin 2Lymphoma, Large-Cell, Immunoblastic 2Lymphoma, Large B-Cell, Diffuse 2Lymphoma, Follicular 2Leukemia, Myeloid, Accelerated Phase 2Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2Carcinoma, Hepatocellular 2Thrombocythemia, Essential 1Sarcoma, Synovial 1

Interventions

Sorafenib 121Nivolumab 36pembrolizumab 32Bevacizumab 28lenvatinib 27Doxorubicin 23Radiosurgery 21Radiofrequency Ablation 20Oxaliplatin 20Hepatectomy 18Fluorouracil 15Capecitabine 15Magnetic Resonance Spectroscopy 14atezolizumab 13Leucovorin 13Cisplatin 13Gemcitabine 11Erlotinib Hydrochloride 11tislelizumab 9Sirolimus 9Radiotherapy 9Irinotecan 9Ipilimumab 9cabozantinib 8Liver Transplantation 8regorafenib 7Ramucirumab 7Folfox protocol 7Embolization, Therapeutic 7sintilimab 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Carcinoma, Hepatocellular × Idarubicin × Clear all
NCT03349957 2018-04-25

TANDEM-IDA

University Hospital, Montpellier

Completed
98 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT01040559 2013-01-09

Chemoembolisation of Non Resectable, Non Metastatic Hepatocellular Carcinomas

Centre Hospitalier Universitaire Dijon

Phase 1 Completed
18 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡